The classic website will no longer be available as of June 25, 2024. Please use the modernized

Key Record Dates Identifier: NCT05428969
Brief Title: A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB)

First Submitted : June 15, 2022
First Submitted that Met QC Criteria : June 17, 2022
First Posted : June 23, 2022

Last Update Submitted that Met QC Criteria : January 16, 2024
Last Update Posted : January 17, 2024